Buy & Sell Novavax Inc (NVAX) – Novavax Inc Price Today
Aura AI Summary
Key Stats
- $1.41BMarket Cap
- HealthSector
- -27.63%3M Drawdown
- $912.32MEnterprise Value
- -Dividend Yield
- 57 daysTypical Hold Time
Novavax Inc (NVAX) is currently valued at a market capitalization of $1.41B, with an enterprise value of $912.32M. Over the past 52 weeks, Novavax Inc has traded between a low of $6.22 and a high of $11.19, highlighting its annual price range. Over the past three months, Novavax Inc has recorded a drawdown of -27.63%, reflecting recent price volatility. On average, investors hold Novavax Inc for approximately 57 days, indicating typical investor behavior on the platform.
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Most Recent News
Verizon shows resilience with a 6% dividend yield, making it a solid defensive stock despite profit challenges.
Verizon's stock has demonstrated resilience recently compared to other telecom carriers, maintaining its status as a solid defensive investment. Despite poor performance in the last bear market, Verizon offers a strong 6% dividend yield that appears ...

US government moves toward equity stakes in AI firms ahead of historic IPOs, reshaping investor ownership.
The US government is actively negotiating to take equity stakes in AI companies like OpenAI and Anthropic ahead of their planned IPOs, following a precedent set by its investment in Intel. This move aims to give the public a share in AI-driven growth...

Trulieve becomes first US cannabis stock listed on NYSE, signaling sector shift.
Trulieve Cannabis Corp. made history by becoming the first U.S. cannabis company to list on the New York Stock Exchange under the ticker TRLV. This milestone was enabled by the Trump administration's reclassification of cannabis to Schedule III for m...
